Edgar Jacoby

5.3k total citations
88 papers, 4.0k citations indexed

About

Edgar Jacoby is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Edgar Jacoby has authored 88 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 47 papers in Computational Theory and Mathematics and 13 papers in Pharmacology. Recurrent topics in Edgar Jacoby's work include Computational Drug Discovery Methods (47 papers), Chemical Synthesis and Analysis (17 papers) and Protein Structure and Dynamics (14 papers). Edgar Jacoby is often cited by papers focused on Computational Drug Discovery Methods (47 papers), Chemical Synthesis and Analysis (17 papers) and Protein Structure and Dynamics (14 papers). Edgar Jacoby collaborates with scholars based in Switzerland, Belgium and France. Edgar Jacoby's co-authors include Ansgar Schuffenhauer, Pierre Acklin, Markus Bredel, Khalil Azzaoui, Jérôme Hert, David J. Wilton, Peter Willett, Michael Engels, Axel Wollmer and Péter Krüger and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Edgar Jacoby

87 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edgar Jacoby Switzerland 31 2.8k 2.0k 486 442 441 88 4.0k
Anneli Karlsson Sweden 9 2.6k 0.9× 1.5k 0.8× 395 0.8× 283 0.6× 345 0.8× 14 3.8k
A. Geoffrey Skillman United States 17 2.5k 0.9× 1.9k 1.0× 614 1.3× 693 1.6× 404 0.9× 26 3.8k
Claudio N. Cavasotto United States 37 2.7k 1.0× 1.8k 0.9× 431 0.9× 576 1.3× 349 0.8× 85 4.2k
Michael M. Mysinger United States 8 2.8k 1.0× 2.5k 1.3× 684 1.4× 558 1.3× 514 1.2× 8 4.4k
Ryan G. Coleman United States 16 2.2k 0.8× 1.6k 0.8× 476 1.0× 357 0.8× 315 0.7× 22 3.4k
Manuel Pastor Spain 30 1.8k 0.7× 1.4k 0.7× 257 0.5× 572 1.3× 244 0.6× 99 3.1k
Ingo Muegge United States 31 2.8k 1.0× 2.3k 1.2× 592 1.2× 1.1k 2.6× 494 1.1× 61 4.7k
Jacob D. Durrant United States 33 2.9k 1.0× 1.7k 0.9× 666 1.4× 487 1.1× 336 0.8× 78 4.2k
Michal Vieth United States 25 2.4k 0.9× 1.4k 0.7× 439 0.9× 727 1.6× 412 0.9× 41 3.7k
Markus A. Lill United States 29 1.9k 0.7× 1.3k 0.7× 431 0.9× 550 1.2× 208 0.5× 93 3.3k

Countries citing papers authored by Edgar Jacoby

Since Specialization
Citations

This map shows the geographic impact of Edgar Jacoby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Jacoby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Jacoby more than expected).

Fields of papers citing papers by Edgar Jacoby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar Jacoby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Jacoby. The network helps show where Edgar Jacoby may publish in the future.

Co-authorship network of co-authors of Edgar Jacoby

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar Jacoby. A scholar is included among the top collaborators of Edgar Jacoby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar Jacoby. Edgar Jacoby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacoby, Edgar, et al.. (2024). Direct-acting antivirals for RSV treatment, a review. Antiviral Research. 229. 105948–105948. 16 indexed citations
2.
Carbajo, Rodrigo J., Edgar Jacoby, Yanting Yin, et al.. (2024). Structure–Activity Relationship of Oxacyclo- and Triazolo-Containing Respiratory Syncytial Virus Polymerase Inhibitors. ACS Medicinal Chemistry Letters. 15(9). 1549–1558. 2 indexed citations
3.
Jacoby, Edgar & J. Brown. (2018). The Future of Computational Chemogenomics. Methods in molecular biology. 1825. 425–450. 5 indexed citations
4.
Wandinger, Sebastian K., Idoya Lahortiga, Kris Jacobs, et al.. (2016). Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling. PLoS ONE. 11(1). e0146100–e0146100. 13 indexed citations
5.
Schopfer, Ulrich, et al.. (2012). Theoretical and Experimental Relationships between Percent Inhibition and IC50 Data Observed in High-Throughput Screening. SLAS DISCOVERY. 18(1). 1–13. 27 indexed citations
6.
Glick, Meir & Edgar Jacoby. (2011). The role of computational methods in the identification of bioactive compounds. Current Opinion in Chemical Biology. 15(4). 540–546. 24 indexed citations
7.
Jacoby, Edgar. (2009). Chemogenomics : methods and applications. Humana Press eBooks. 8 indexed citations
8.
Jacoby, Edgar & Andrea Mozzarelli. (2009). Chemogenomic Strategies to Expand the Bioactive Chemical Space. Current Medicinal Chemistry. 16(33). 4374–4381. 19 indexed citations
9.
Jacoby, Edgar, Andreas Boettcher, Lorenz M. Mayr, et al.. (2009). Knowledge-Based Virtual Screening: Application to the MDM4/p53 Protein–Protein Interaction. Methods in molecular biology. 575. 173–194. 17 indexed citations
10.
Efremov, Roman G., Anton O. Chugunov, Timothy V. Pyrkov, et al.. (2007). Molecular Lipophilicity in Protein Modeling and Drug Design. Current Medicinal Chemistry. 14(4). 393–415. 121 indexed citations
11.
Azzaoui, Khalil, Jacques Hamon, Bernard Faller, et al.. (2007). Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data. ChemMedChem. 2(6). 874–880. 127 indexed citations
12.
Jacoby, Edgar, Rochdi Bouhelal, Marc Gerspacher, & Klaus Seuwen. (2006). The 7 TM G‐Protein‐Coupled Receptor Target Family. ChemMedChem. 1(8). 760–782. 275 indexed citations
13.
Pyrkov, Timothy V., Yuri Kosinsky, Alexander S. Arseniev, et al.. (2006). Complementarity of hydrophobic properties in ATP‐protein binding: A new criterion to rank docking solutions. Proteins Structure Function and Bioinformatics. 66(2). 388–398. 22 indexed citations
14.
Jacoby, Edgar, Ansgar Schuffenhauer, Khalil Azzaoui, et al.. (2005). Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening Collection. Current Topics in Medicinal Chemistry. 5(4). 397–411. 51 indexed citations
15.
Bredel, Markus & Edgar Jacoby. (2004). Chemogenomics: an emerging strategy for rapid target and drug discovery. Nature Reviews Genetics. 5(4). 262–275. 253 indexed citations
16.
Jacoby, Edgar. (2002). Biphenyls as potential mimetics of protein α-helix. Bioorganic & Medicinal Chemistry Letters. 12(6). 891–893. 48 indexed citations
17.
Spedding, Michael, Adrian Newman‐Tancredi, Mark J. Millan, et al.. (1998). Interaction of the anxiogenic agent, RS-30199, with 5-HT1A receptors: modulation of sexual activity in the male rat. Neuropharmacology. 37(6). 769–780. 10 indexed citations
18.
Jacoby, Edgar, Péter Krüger, Michael Engels, et al.. (1994). Modeling of G-Protein Coupled Receptors with Bacteriorhodopsin as a Template. A Novel Approach Based on Interaction Energy Differences. Journal of Receptor Research. 14(3-4). 167–186. 19 indexed citations
19.
Jacoby, Edgar, Péter Krüger, Yaşar Karataş, & Axel Wollmer. (1993). Distinction of Structural Reorganisation and Ligand Binding in the T R Transition of Insulin on the Basis of Allosteric Models. Biological Chemistry Hoppe-Seyler. 374(7-12). 877–886. 12 indexed citations
20.
Grötzinger, Joachim, et al.. (1991). A model for the C5a receptor and for T its interaction with the ligand. Protein Engineering Design and Selection. 4(7). 767–771. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anneli Karlsson Breakdown of academic impact, for papers by A. Geoffrey Skillman Breakdown of academic impact, for papers by Claudio N. Cavasotto Breakdown of academic impact, for papers by Michael M. Mysinger Breakdown of academic impact, for papers by Ryan G. Coleman Breakdown of academic impact, for papers by Manuel Pastor Breakdown of academic impact, for papers by Ingo Muegge Breakdown of academic impact, for papers by Jacob D. Durrant Breakdown of academic impact, for papers by Michal Vieth Breakdown of academic impact, for papers by Markus A. Lill
Rankless by CCL
2026